JAGX - Jaguar Health, Inc.
| Previous Close | 0.15 |
| Open | 0.15 |
| Bid | 0.14 x 800 |
| Ask | 0.15 x 1200 |
| Day's Range | 0.14 - 0.15 |
| 52 Week Range | 0.10 - 0.99 |
| Volume | 2,278,605 |
| Avg. Volume | 8,550,735 |
| Market Cap | 25.553M |
| Beta | -0.45 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.51 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.25 |
- ACCESSWIRE•2 days ago
Jaguar Health, Inc. Reports First-Quarter 2018 Operational Updates and Voting Results from 2018 Annual Meeting of Stockholders
SAN FRANCISCO, CA / ACCESSWIRE / May 18, 2018 / Jaguar Health, Inc. (JAGX) ("Jaguar" or the "Company"), a commercial stage natural-products pharmaceutical company focused on developing novel, sustainably derived gastrointestinal products on a global basis, announced today that the Company filed on May 15, 2018 its first quarter report on Form 10-Q with the U.S. Securities and Exchange Commission (SEC). The Company also today announced voting results from Jaguar's 2018 Annual Meeting of Stockholders, which was held earlier today. Additionally, Jaguar announced today that Company management is hosting a conference call on Monday, May 21st at 4:30 p.m. Eastern Time for investors and analysts.
- Simply Wall St.•5 days ago
Jaguar Health Inc (NASDAQ:JAGX): Does The Earnings Decline Make It An Underperformer?
After looking at Jaguar Health Inc’s (NASDAQ:JAGX) latest earnings announcement (31 December 2017), I found it useful to revisit the company’s performance in the past couple of years and assessRead More...
- ACCESSWIRE•5 days ago
''Under Pressure'' Episode of Merce Uses Comedy to Help People Living with HIV Talk About Diarrhea
SAN FRANCISCO, CA / ACCESSWIRE / May 15, 2018 / Napo Pharmaceuticals, Inc. (Napo), a human health company developing and commercializing novel gastrointestinal prescription products from plants used traditionally in rainforest areas, and a wholly-owned subsidiary of Jaguar Health, Inc. (JAGX) (Jaguar), announced today that, in conjunction with its continuing efforts to raise awareness around the problem of HIV-related diarrhea, the Company is supporting the production of Merce, an award-winning musical comedy web series about a middle-aged, HIV-positive man living in New York City, which aims to show that 'Life can be positive when you're positive!' A special short episode called ''Under Pressure'' has been produced by the Merce team that Napo will use in its awareness campaign. The episode can be viewed at http://enoughdiarrhea.com/video.html.
- ACCESSWIRE•6 days ago
Free Breakfast Technical Briefing on Intrexon and Three Other Biotech Stocks
Under assessment are the following four stocks: Intrexon Corp. (NYSE: XON), Iovance Biotherapeutics Inc. (NASDAQ: IOVA), Jaguar Health Inc. (NASDAQ: JAGX), and Jazz Pharmaceuticals PLC (NASDAQ: JAZZ). Germantown, Maryland-based Intrexon Corp.'s stock plummeted 19.64%, finishing last Friday's trading session at $14.98.
- GlobeNewswire•13 days ago
Research Report Identifies Jaguar Animal Health, Dollar Tree, WPX Energy, Abaxis, Lear, and Baker Hughes with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
NEW YORK, May 07, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Jaguar ...
- ACCESSWIRE•last month
Experts Highlight that Immune System Activation in Aging Patients Living with HIV/AIDS Triggers Effects Such as "Leaky Gut", Which Can Lead to Diarrhea
Mytesi for HIV-related Diarrhea Now on ADAP Formularies in 22 States SAN FRANCISCO, CA / ACCESSWIRE / April 19, 2018 / Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), ...
- ACCESSWIRE•last month
Jaguar Subsidiary Napo Pharmaceuticals Signs Agreement with the ADAP Crisis Task Force for Mytesi
Agreement Provides Pricing for Mytesi to Each U.S. State's AIDS Drug Assistance Program (ADAP) - Organizations that Provide HIV-related Services and Approved Medications to More than Half a Million People ...
- ACCESSWIRE•2 months ago
Jaguar Health Appoints Jonathan B. Siegel to Board of Directors
SAN FRANCISCO, CA / ACCESSWIRE / April 2, 2018 / Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), a commercial stage natural-products pharmaceutical company focused on ...
- ACCESSWIRE•2 months ago
Jaguar Health Announces Up to $16.2 Million in Equity Financings in Separate Private Placement Investments, Including Investment by Sagard Capital Partners, L.P., to Continue Commercialization of FDA-Approved Mytesi
Largest Investor Locked in for 12 Months SAN FRANCISCO, CA / ACCESSWIRE / March 26, 2018 / Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), a commercial stage natural-products ...
- Simply Wall St.•2 months ago
Why Jaguar Health Inc’s (NASDAQ:JAGX) CEO Pay Matters To You
Leading Jaguar Health Inc (NASDAQ:JAGX) as the CEO, Lisa Conte took the company to a valuation of US$32.95M. Understanding how CEOs are incentivised to run and grow their company isRead More...
- Business Wire•2 months ago
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Jaguar Health, Inc.
Levi & Korsinsky announces it has commenced an investigation of Jaguar Health, Inc. concerning possible breaches of fiduciary duty. To obtain additional informat
- ACCESSWIRE•2 months ago
Jaguar Health, Pipeline Review, Analyst Ratings, Milestones
NEW YORK, NY / ACCESSWIRE / March 13, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...
- ACCESSWIRE•2 months ago
Today’s Research Reports on Stocks to Watch: Atossa Genetics and Jaguar Health
NEW YORK, NY / ACCESSWIRE / March 9, 2018 / Shares of Atossa ended in the green on Thursday but fell deep into the red in after-hours trading when it announced its financial report for 2017. Shares of ...
- ACCESSWIRE•2 months ago
FDA Indicates that Jaguar's Reasonable Expectation of Effectiveness Technical Section is Complete for Use of Canalevia for Treatment of Chemotherapy-Induced Diarrhea in Dogs
SAN FRANCISCO, CA / ACCESSWIRE / March 8, 2018 / Jaguar Health, Inc. (NASDAQ: JAGX) (Jaguar or the Company), a commercial stage natural-products pharmaceuticals company focused on developing novel, sustainably ...
- GlobeNewswire•2 months ago
Report: Developing Opportunities within TripAdvisor, Glu Mobile, KeyCorp, SMART SAND INC, Jaguar Animal Health, and Cleveland-Cliffs — Future Expectations, Projections Moving into 2018
NEW YORK, March 05, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
- ACCESSWIRE•3 months ago
Jaguar Health Subsidiary, Napo Pharmaceuticals, Signs Agreement with Pharmacy Services Provider "Transition Patient Services" to Establish Nationwide Pilot "Mytesi Direct" Program
SAN FRANCISCO, CA / ACCESSWIRE / March 2, 2018 / Jaguar Health, Inc. (NASDAQ: JAGX) (Jaguar or the Company), a commercial stage natural-products pharmaceuticals company focused on developing novel, sustainably ...
- Simply Wall St.•3 months ago
How Financially Strong Is Jaguar Health Inc (NASDAQ:JAGX)?
Investors are always looking for growth in small-cap stocks like Jaguar Health Inc (NASDAQ:JAGX), with a market cap of US$17.48M. However, an important fact which most ignore is: how financiallyRead More...
- Business Wire•4 months ago
Jaguar Health Provides Updates Regarding Commercial, Educational & Product Development Programs and 2017 Results for Mytesi Since Merger (August–December 2017)
Jaguar Health, Inc. , a commercial stage natural-products pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis, today provided the following updates regarding commercial, educational and product development programs and 2017 results.
- Business Wire•4 months ago
Jaguar Health to Host Conference Call Monday, January 22nd at 4:15 p.m. Eastern Time to Provide Updates Regarding Jaguar and Napo Pharmaceuticals Commercial, Educational & Product Development Activities and 2017 Results
Jaguar Health, Inc. , a commercial stage natural-products pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis, announced today that Company management will host a conference call on Monday, January 22, 2018 at 4:15 p.m.
- Business Wire•4 months ago
Napo Pharmaceuticals Comments on the Passing of HIV/AIDS Activist and Research Pioneer Dr. Mathilde Krim
Napo Pharmaceuticals, Inc. , a human health company developing and commercializing novel gastrointestinal prescription products from plants used traditionally in rainforest areas, and a wholly-owned subsidiary of Jaguar Health, Inc.
- Simply Wall St.•4 months ago
Jaguar Health Inc (NASDAQ:JAGX): Has Recent Earnings Growth Beaten Long-Term Trend?
Assessing Jaguar Health Inc’s (NASDAQ:JAGX) past track record of performance is a valuable exercise for investors. It enables us to reflect on whether the company has met or exceed expectations,Read More...
- ACCESSWIRE•5 months ago
WallStreet Research(TM) Announces Release of Corporate Profile Coverage on Jaguar Health, Inc. (NASDAQ: JAGX)
NEW YORK, NY / ACCESSWIRE / December 26, 2017 / WallStreet Research™ (WSR), a top-ranked independent research firm with a history spanning over three decades, today announced that it has initiated Corporate ...
- Business Wire•5 months ago
Jaguar Health and Dubai-based Seed Mena Enter Collaboration Agreement for Equilevia, Jaguar’s Personalized, Premium Product for Total Gut Health and Wellness in Horses
Jaguar Health, Inc. , a natural-products pharmaceuticals company focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis, announced today that it has entered into a collaboration agreement with Seed Mena Businessmen Services LLC for Equilevia™, Jaguar’s non-prescription, personalized, premium product ...
- Business Wire•5 months ago
New Survey Finds People Living With HIV With Diarrhea Often Suffer in Silence
Napo Pharmaceuticals, Inc. , a human health company developing and commercializing novel gastrointestinal prescription products from plants used traditionally in rainforest areas, and a wholly-owned subsidiary of Jaguar Health, Inc.
